David Agus
16Patents
5h-index
11Co-inventors
63Inventor score
Filing activity: Nov 19, 1999 → Nov 7, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6221904A | Method for increasing the concentration of ascorbic acid in brain tissues of a subject | Human Necessities | 25 | Expired |
| US8333964B2 | ErbB antagonists for pain therapy | Chemistry; Metallurgy | 24 | Active |
| US9141756B1 | Multi-scale complex systems transdisciplinary analysis of response to therapy | Physics | 18 | Active |
| US7384940B2 | Method of treating cancer using kinase inhibitors | Physics | 9 | Expired |
| US6262111A | Method for increasing the concentration of ascorbic acid in brain tissues of a subject | Human Necessities | 5 | Expired |
| US6608106B2 | Method for increasing the concentration of ascorbic acid in brain tissues of a subject | Human Necessities | 2 | Expired |
| US7955810B2 | Positive selection of serum proteins for proteomic analysis | Physics | 2 | Active |
| US7425565B2 | Use of benzothiopenes to treat and prevent prostate cancer | Human Necessities | 2 | Expired |
| US7816647B2 | Bi-directional system for mass spectrometry | Electricity | 2 | Active |
| US12085568B2 | Machine learning for digital pathology | Physics | 1 | Active |
| US7736853B2 | Methods of diagnosis of androgen-dependent prostate cancer, prostate cancer undergoing androgen withdrawal, and androgen-independent prostate cancer | Physics | 1 | Active |
| US10867706B2 | Multi-scale complex systems transdisciplinary analysis of response to therapy | Physics | 0 | Active |
| US7803546B2 | Method of screening for sensitivity to kinase inhibitor therapy | Physics | 0 | Active |
| US12354012B2 | Histopathology classification through machine self-learning of “tissue fingerprints” | Physics | 0 | Active |
| US6420420B2 | Method for increasing the concentration of ascorbic acid in brain tissue of a subject | Human Necessities | 0 | Expired |
| US11835524B2 | Machine learning for digital pathology | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.